129 related articles for article (PubMed ID: 4395088)
1. Evaluation of a new alpha-blocking vasodilator agent (thymoxamine) in peripheral vascular disease.
Kane SP
Br J Surg; 1970 Dec; 57(12):921-6. PubMed ID: 4395088
[No Abstract] [Full Text] [Related]
2. [Treatment of functional changes in arteriosclerotic chronic obliterating peripheral arterial diseases (COPA) and Buerger's and Raynaud's diseases with pharmacological sympathicolysis, with or without indirect surgical treatment].
Bagliani A; Borri P; Taborelli R
Minerva Cardioangiol; 1973 Jun; 21(6):439-52. PubMed ID: 4720185
[No Abstract] [Full Text] [Related]
3. Thymoxamine (Opilon).
Drug Ther Bull; 1969 Dec; 7(25):99-100. PubMed ID: 5357789
[No Abstract] [Full Text] [Related]
4. Haemodynamic action of thymoxamine (an alpha-adrenergic blocking agent) in occlusive peripheral arterial disease.
Myers KA; Hobbs JT; Irvine WT
Cardiovasc Res; 1968 Oct; 2(4):360-6. PubMed ID: 4882442
[No Abstract] [Full Text] [Related]
5. Preliminary results in the treatment of peripheral arteriopathies with a new pharmacologic substance: I-(2"pyrimidyl)4 piperonyl piperazine (ET 495).
Royer RJ
Bibl Cardiol; 1969; 26():174-9. PubMed ID: 5402343
[No Abstract] [Full Text] [Related]
6. [Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study].
Coscia M
Minerva Cardioangiol; 1972 Sep; 20(9):497-504. PubMed ID: 4561065
[No Abstract] [Full Text] [Related]
7. [The vasoactivogram in the treatment of peripheral arteriopathies].
Romeo S; Spinella G; Sciacchitanto D
Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
[No Abstract] [Full Text] [Related]
8. [Clinical experience with bencyclane in the treatment of vascular obliterations in the limbs].
Krakovskij NI; Taranovic VA
Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1435+. PubMed ID: 5536665
[No Abstract] [Full Text] [Related]
9. On the treatment of vascular insufficiencies of the labyrinth with thymoxamine.
Gill NW
J Laryngol Otol; 1968 Mar; 82(3):231-45. PubMed ID: 5640991
[No Abstract] [Full Text] [Related]
10. [Prolonged intravenous and intra-arterial administration of large doses of Raubasine in peripheral arterial diseases].
Raso AM; Silvestrini P
Minerva Med; 1973 Mar; 64(19):961-9. PubMed ID: 4703313
[No Abstract] [Full Text] [Related]
11. [Clinical study of moxisylyte citrate].
Thénot A
Clin Ter; 1970 Nov; 55(4):305-12. PubMed ID: 4397031
[No Abstract] [Full Text] [Related]
12. DRUGS FOR PERIPHERAL VASCULAR DISEASE.
FRIEND DG
Clin Pharmacol Ther; 1964; 5():666-72. PubMed ID: 14209779
[No Abstract] [Full Text] [Related]
13. [Experiences with bencyclane in peripheral disorders of arterial blood supply].
Alánt O; Horváth N
Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1403+. PubMed ID: 5536654
[No Abstract] [Full Text] [Related]
14. [Clinical use of thymoxamine in peripheral arterial pathology].
Ghiglino GC; Viacava A; Gori A; Misuri A; Lucertini G; Pelagatti M
Clin Ter; 1983 Apr; 105(2):103-7. PubMed ID: 6222862
[No Abstract] [Full Text] [Related]
15. [Treatment of arteriopathies of limbs by xanthinol nicotinate].
Elbaz C
Phlebologie; 1969; 22(1):105-11. PubMed ID: 5775643
[No Abstract] [Full Text] [Related]
16. [Chronic occlusion of the arteries of the extremities. Activation of circulation].
Widner LK
Minerva Med; 1967 May; 58(39):1844-7. PubMed ID: 6026646
[No Abstract] [Full Text] [Related]
17. Vasodilator drugs and peripheral vascular disease.
Drug Ther Bull; 1972 Nov; 10(23):91-2. PubMed ID: 4144248
[No Abstract] [Full Text] [Related]
18. [Use of a new sympatholytic drug in therapy of chronic peripheral obliterating artery diseases].
Vittori C; Taborelli G; Taborelli R
Minerva Cardioangiol; 1965 Sep; 13(9):585-91. PubMed ID: 5851172
[No Abstract] [Full Text] [Related]
19. Arterial disorders of the extremities: clinical syndromes; assessment and measurement.
Abramson DI
Arch Phys Med Rehabil; 1968 Jun; 49(6):315-25. PubMed ID: 5667243
[No Abstract] [Full Text] [Related]
20. [Effect of surheme on improved blood flow in limbs].
Wesolowski J; Hubl S; Godziemba-Maliszewska E
Wiad Lek; 1972 Jul; 25(14):1297-300. PubMed ID: 5054661
[No Abstract] [Full Text] [Related]
[Next] [New Search]
